Policy coherence in US tobacco control: beyond FDA regulation.

Código QR

Policy coherence in US tobacco control: beyond FDA regulation.

Guardado en:

Detalles Bibliográficos
Autores principales:	Joshua S Yang, Thomas E Novotny
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2009
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/f51467de24f748538a7c2cfa12d66633
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

US Tobacco 21 is Paving the Way for a Tobacco Endgame
por: Samuel C J Kim, et al.
Publicado: (2021)

Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents.
por: Risako Shirane, et al.
Publicado: (2012)

FDA consumer
Publicado: (1972)

Avoiding “A Massive Spin-off Effect in West Africa and Beyond”: The Tobacco Industry’s Role in Stymieing Tobacco Control in Nigeria
por: C.O. Egbe, et al.
Publicado: (2017)

Cuba-U.S. scientific collaboration: Beyond the embargo.
por: Guillermo Armando Ronda-Pupo
Publicado: (2021)

Tobacco control policies and smoking cessation treatment utilization: A moderated mediation analysis.
por: Johannes Thrul, et al.
Publicado: (2021)

A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices
por: Samantha L. Cohen, et al.
Publicado: (2022)

Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
por: Bin Wu, et al.
Publicado: (2021)

"Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
por: Katherine E Smith, et al.
Publicado: (2010)

The association between tobacco control policy implementation and country-level socioeconomic factors in 31 European countries
por: Ariadna Feliu, et al.
Publicado: (2021)

Advancing digital health: FDA innovation during COVID-19
por: Kushal Kadakia, et al.
Publicado: (2020)

Digital Surveillance to Identify California Alternative and Emerging Tobacco Industry Policy Influence and Mobilization on Facebook
por: Qing Xu, et al.
Publicado: (2021)

Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents.
por: Gary J Fooks, et al.
Publicado: (2011)

Traditional Cigarette and Poly-Tobacco Use Are Associated with Medical Opioid Use in Rural Areas of the US
por: Mariaelena Gonzalez, et al.
Publicado: (2021)

Tobacco control
Publicado: (1992)

The Mexico SimSmoke tobacco control policy model: Development of a simulation model of daily and nondaily cigarette smoking.
por: Luz María Sánchez-Romero, et al.
Publicado: (2021)

A qualitative study to assess perceptions, barriers, and motivators supporting smokeless tobacco cessation in the US fire service.
por: Nattinee Jitnarin, et al.
Publicado: (2021)

Robotic stapler use: Is it safe?-FDA database analysis across multiple surgical specialties.
por: Zane Giffen, et al.
Publicado: (2021)

Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs
por: Shuo Gu, et al.
Publicado: (2018)

FDA-MIMO Beampattern Synthesis with an Analytical Method
por: Changlin Zhou, et al.
Publicado: (2021)

Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging.
por: Selda Ulucanlar, et al.
Publicado: (2014)

Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing
por: Alexandre Vivot, et al.
Publicado: (2017)

The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
por: Stan Benjamens, et al.
Publicado: (2020)

Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
por: Heide Weishaar, et al.
Publicado: (2012)

Backslide or forward progress? Virtual care at U.S. healthcare systems beyond the COVID-19 pandemic
por: Spencer D. Dorn
Publicado: (2021)

Racism, gun ownership and gun control: biased attitudes in US whites may influence policy decisions.
por: Kerry O'Brien, et al.
Publicado: (2013)

Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
por: Yusuke Kan, et al.
Publicado: (2021)

The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.
por: Pascal Johann, et al.
Publicado: (2021)

Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System
por: Liwei Wang, et al.
Publicado: (2017)

FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science
por: Heike Sichtig, et al.
Publicado: (2019)

Tobacco price and use following California Proposition 56 tobacco tax increase.
por: Christian Gunadi, et al.
Publicado: (2021)

Transcription Factor Forkhead Regulates Expression of Antimicrobial Peptides in the Tobacco Hornworm, Manduca sexta
por: Xue Zhong, et al.
Publicado: (2017)

How does the tobacco industry attempt to influence marketing regulations? A systematic review.
por: Emily Savell, et al.
Publicado: (2014)

Beyond words: From jaguar population trends to conservation and public policy in Mexico.
por: Gerardo Ceballos, et al.
Publicado: (2021)

Control of axillary bud growth in tobacco through toxin gene expression system
por: Jing Lv, et al.
Publicado: (2021)

Building blocks for tobacco control a handbook.
Publicado: (2004)

Functional Characterization of Populus PsnSHN2 in Coordinated Regulation of Secondary Wall Components in Tobacco
por: Yingying Liu, et al.
Publicado: (2017)

Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?
por: Stiehm Michael, et al.
Publicado: (2020)

US law enforcement policy predictors of race-specific police fatalities during 2015-16.
por: Marilyn D Thomas, et al.
Publicado: (2021)

FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity.
por: Alex Lublin, et al.
Publicado: (2011)